NCT01846650View on ClinicalTrials.gov

A Bioequivalence Study of Capecitabine Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Metastatic Breast Cancer or Metastatic Colorectal Cancer
Interventions
DRUG

Capecitabine tablets

Single oral Capecitabine tablets 2000mg qd

DRUG

XELODA

Single oral XELODA 2000mg qd

Trial Locations (1)

Unknown

First Affiliated Hospital of Fourth Military Medical University, Xi’an

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY